Nisheeth Ranjan

Angel investor in San Francisco

Invests in AI

Nisheeth Ranjan's investor profile lists AI alongside Fintech, Healthcare & Biotech and Digital Health & HealthTech, at early-stage venture. The record holds 2 deals, among them Netscape, AOL and Trulia.

Email Investor

Email Investor

Credits to line up before an early-stage round

Nisheeth Ranjan backs companies at early-stage venture. A few of the larger credit programs on AI Perks for teams at that point:

Portfolio on record

Portfolio companies

  • Netscape, AOL
  • Trulia

Investment focus

Backs startups in
Artificial Intelligence, Fintech, Healthcare & Biotech, Digital Health & HealthTech, Biotech & Pharma, MedTech & Medical Devices and 9 more
Rounds
Early-stage venture
Profile
Angel investor
Deals on record
2
Based in
San Francisco, United States

Ready to pitch AI investors?

AI Perks profiles show public professional information only, so there are no contact details here. Continue to find investors, send your pitch and track the replies.

Email Investor

Email Investor

More AI investors on AI Perks

Browse all AI investors

Questions founders ask

Does Nisheeth Ranjan invest in AI startups?
Yes. Artificial Intelligence is one of the sectors on Nisheeth Ranjan's investor profile, together with Fintech, Healthcare & Biotech and Digital Health & HealthTech. The stages on record are early-stage venture.
Which companies has Nisheeth Ranjan backed?
The record lists 2 deals, including Netscape, AOL and Trulia. None of them has a perk listed on AI Perks yet.
What credits can a startup claim before pitching Nisheeth Ranjan?
For a company raising an early-stage round, AI Perks lists credits such as Retool (up to $225,000), Databricks (up to $50,000), Claude (up to $20,000) and Redis (up to $10,000), with each program's terms and how to apply.
Does AI Perks publish investor contact details?
No. AI Perks profiles show public professional information only: name, role, location, stages, sectors and the portfolio on record. To reach investors, continue with the Email Investor button below.Email Investor

Email Investor

Source: public professional information. Is this you? Request removal

Email Investor

Email Investor